• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人8-氧代鸟嘌呤DNA糖基化酶1(hOGG1)丝氨酸326位半胱氨酸的基因多态性及其与查谟和克什米尔地区乳腺癌的关联

Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir.

作者信息

Nagpal Ashna, Verma Sonali, Shah Ruchi, Bhat Ghulam R, Bhat Amrita, Bakshi Divya, Sharma Bhanu, Kaul Sandeep, Kumar Rakesh

机构信息

School of Biotechnology, Shri Mata Vaishno Devi University, Katra, Jammu and Kashmir, India.

Department of Oncology, Shri Mata Vaishno Devi Superspeciality Narayana Hospital, Katra, Jammu and Kashmir, India.

出版信息

Indian J Cancer. 2020 Apr-Jun;57(2):187-189. doi: 10.4103/ijc.IJC_676_18.

DOI:10.4103/ijc.IJC_676_18
PMID:32167073
Abstract

BACKGROUND

8-Oxo-7, 8-dihydro-2'-deoxyguanosine (8-oxodG) is a potent DNA damage marker that leads to cellular oxidative stress. It is a DNA-repair enzyme that participates in "8-oxodG" DNA adducts removal. Previous studies show weak associations of rs1052133 (hOGG1) in breast cancer patients of Northern India. We performed this study to explore the variant rs1052133 (hOGG1) with breast in the population of Jammu and Kashmir (J and K).

METHOD

A polymerase chain reaction-restriction fragment length polymorphism -based single-nucleotide polymorphism (SNP) genotypic study was carried out in peripheral blood samples of 165 breast cancer patients and 200 healthy controls, using specific primers. Sanger sequencing verified the results.

RESULTS

hOGG1-Ser326Cys polymorphism occurred frequently in cases as compared with controls. Data were evaluated by SPSS V.13 software, following Hardy-Weinberg equilibrium (P = 0.002 at OR 2.57; 95% CI [1.68-3.93]), which showed that the SNP rs1052133 had a significant association with increased risk of breast cancer.

CONCLUSION

Overall, the results of this analysis show that the hOGG1-Ser326Cys polymorphism may be associated with an increased risk for breast cancer in the J and K population.

摘要

背景

8-氧代-7,8-二氢-2'-脱氧鸟苷(8-氧代脱氧鸟苷,8-oxodG)是一种强效的DNA损伤标志物,可导致细胞氧化应激。它是一种DNA修复酶,参与“8-氧代脱氧鸟苷”DNA加合物的清除。先前的研究表明,印度北部乳腺癌患者中rs1052133(hOGG1)存在弱关联。我们开展这项研究,以探究查谟和克什米尔(J和K)人群中rs1052133(hOGG1)基因变异与乳腺癌的关系。

方法

采用基于聚合酶链反应-限制性片段长度多态性的单核苷酸多态性(SNP)基因分型研究,使用特异性引物对165例乳腺癌患者和200例健康对照者的外周血样本进行检测。桑格测序验证结果。

结果

与对照组相比,hOGG1-Ser326Cys多态性在病例组中频繁出现。数据采用SPSS V.13软件进行评估,符合哈迪-温伯格平衡(优势比为2.57时P = 0.002;95%可信区间[1.68 - 3.93]),这表明SNP rs1052133与乳腺癌风险增加显著相关。

结论

总体而言,该分析结果表明,hOGG1-Ser326Cys多态性可能与J和K人群中乳腺癌风险增加有关。

相似文献

1
Genetic polymorphism of hOGG1 ser326cys and its association with breast cancer in Jammu and Kashmir.人8-氧代鸟嘌呤DNA糖基化酶1(hOGG1)丝氨酸326位半胱氨酸的基因多态性及其与查谟和克什米尔地区乳腺癌的关联
Indian J Cancer. 2020 Apr-Jun;57(2):187-189. doi: 10.4103/ijc.IJC_676_18.
2
The hOGG1 Ser326Cys Gene Polymorphism and Breast Cancer Risk in Saudi Population.沙特人群中hOGG1基因Ser326Cys多态性与乳腺癌风险
Pathol Oncol Res. 2017 Jul;23(3):525-535. doi: 10.1007/s12253-016-0146-6. Epub 2016 Nov 7.
3
DNA base excision repair genes variants rs25487 (X-ray repair cross-complementing 1) and rs1052133 (human 8-oxoguanine glycosylase 1) with susceptibility to ovarian cancer in the population of the Jammu region, India.印度查谟地区人群中DNA碱基切除修复基因变体rs25487(X射线修复交叉互补蛋白1)和rs1052133(人8-氧鸟嘌呤糖基化酶1)与卵巢癌易感性的关系
J Cancer Res Ther. 2019 Oct-Dec;15(6):1270-1275. doi: 10.4103/jcrt.JCRT_65_18.
4
Ser326Cys polymorphism in DNA repair genes hOGG1 in breast cancer women.乳腺癌女性DNA修复基因hOGG1中的Ser326Cys多态性
Pol J Pathol. 2008;59(4):201-4.
5
hOGG1 Ser326Cys polymorphism and risk of childhood acute lymphoblastic leukemia in a Chinese population.HOGG1 Ser326Cys 多态性与中国儿童急性淋巴细胞白血病的风险。
Cancer Sci. 2011 Jun;102(6):1123-7. doi: 10.1111/j.1349-7006.2011.01928.x. Epub 2011 Apr 26.
6
Association of Base Excision Repair Gene hOGG1 Ser326Cys Polymorphism with Susceptibility to Cervical Squamous Cell Carcinoma and High-Risk Human Papilloma Virus Infection in a Chinese Population.碱基切除修复基因hOGG1 Ser326Cys多态性与中国人群宫颈鳞状细胞癌易感性及高危型人乳头瘤病毒感染的相关性
Genet Test Mol Biomarkers. 2019 Feb;23(2):138-144. doi: 10.1089/gtmb.2018.0150. Epub 2019 Jan 16.
7
hOGG1 Ser326Cys polymorphism is associated with risk of bladder cancer in a Chinese population: a case-control study.HOGG1 Ser326Cys 多态性与中国人群膀胱癌风险相关:一项病例对照研究。
Cancer Sci. 2012 Jul;103(7):1215-20. doi: 10.1111/j.1349-7006.2012.02290.x. Epub 2012 May 7.
8
Protective association exhibited by the single nucleotide polymorphism (SNP) rs1052133 in the gene human 8-oxoguanine DNA glycosylase (hOGG1) with the risk of squamous cell carcinomas of the head & neck (SCCHN) among north Indians.单核苷酸多态性(SNP)rs1052133 在基因人 8-氧鸟嘌呤 DNA 糖基化酶(hOGG1)中与北印度人头颈部鳞状细胞癌(SCCHN)风险的保护关联。
Indian J Med Res. 2011 Jun;133(6):605-12.
9
The hOGG1 Ser326Cys gene polymorphism and the risk of coronary ectasia in the Chinese population.HOGG1 基因 Ser326Cys 多态性与中国人冠状动脉扩张风险的关系。
Int J Mol Sci. 2014 Jan 22;15(1):1671-82. doi: 10.3390/ijms15011671.
10
rs1052133 Genotypes and Risk of Childhood Acute Lymphoblastic Leukemia in a Taiwanese Population.rs1052133 基因型与台湾地区儿童急性淋巴细胞白血病风险的相关性。
In Vivo. 2019 Jul-Aug;33(4):1081-1086. doi: 10.21873/invivo.11576.

引用本文的文献

1
Genetic Polymorphisms in Base Excision Repair (BER) and Nucleotide Excision Repair (NER) Pathways as Potential Biomarkers for Gynecological Cancers: A Comprehensive Literature Review.碱基切除修复(BER)和核苷酸切除修复(NER)途径中的基因多态性作为妇科癌症的潜在生物标志物:一项综合文献综述
Cancers (Basel). 2025 Jun 27;17(13):2170. doi: 10.3390/cancers17132170.
2
North India Cancer Risk: A Detailed Review with Focus on Jammu and Kashmir Demographics.北印度癌症风险:一项详细的综述,重点关注查谟和克什米尔的人口统计学。
Asian Pac J Cancer Prev. 2024 Oct 1;25(10):3489-3506. doi: 10.31557/APJCP.2024.25.10.3489.
3
Impact of Polymorphism in Base Excision Repair and Nucleotide Excision Repair Genes and Risk of Cervical Cancer: A Case-Control Study.
碱基切除修复和核苷酸切除修复基因多态性与宫颈癌风险的关系:病例对照研究。
Asian Pac J Cancer Prev. 2022 Apr 1;23(4):1291-1300. doi: 10.31557/APJCP.2022.23.4.1291.